{
    "organizations": [],
    "uuid": "a4cf18f65d707c43c4f700383d1b7c8f3eff2460",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-sanochemia-pharmazeutika-successfu/brief-sanochemia-pharmazeutika-successfully-completes-financing-for-clinical-development-of-tolperisone-usa-idUSFWN1SD02H",
    "ord_in_thread": 0,
    "title": "Sanochemia Pharmazeutika Successfully Completes Financing For Clinical Development Of Tolperisone USA",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 7 (Reuters) - SANOCHEMIA PHARMAZEUTIKA AG:\n* SUCCESSFULLY COMPLETES FINANCING FOR CLINICAL DEVELOPMENT OF TOLPERISONE USA\n* NEURANA RAISED $ 60 MILLION IN FUNDING Source text for Eikon: (Gdynia Newsroom)\nOur ",
    "published": "2018-05-07T14:34:00.000+03:00",
    "crawled": "2018-05-08T16:22:09.017+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "sanochemia",
        "pharmazeutika",
        "ag",
        "successfully",
        "completes",
        "financing",
        "clinical",
        "development",
        "tolperisone",
        "usa",
        "neurana",
        "raised",
        "million",
        "funding",
        "source",
        "text",
        "eikon",
        "gdynia",
        "newsroom"
    ]
}